Monday, August 31, 2026

NASDAQ 100 Rises By 12% In The Last 21 Sessions

ViaNews Editorial Team

November 30, 2023

NASDAQ 100 Rises By 12% In The Last 21 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 12.28% for the last 21 sessions. At 19:10 EST on Wednesday, 29 November, NASDAQ 100 (NDX) is $16,095.90.

Volume

Today's last reported volume for NASDAQ 100 is 168480131, 93.35% below its average volume of 2535433187.67.

About NASDAQ 100's yearly highs and lows, it's 50.84% up from its 52-week low and 0.44% down from its 52-week high.

Volatility

NASDAQ 100's last week, last month's, and last quarter's current intraday variation average was 0.02%, 0.58%, and 0.83%, respectively.

NASDAQ 100's highest amplitude of average volatility was 0.18% (last week), 0.77% (last month), and 0.83% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NASDAQ 100's is considered to be oversold (<=20).

Previous days news about NASDAQ 100 (NDX)

  • Nasdaq 100 forecast: hovers - 28 November 2023. According to DailyForex on Tuesday, 28 November, "I have no interest in shorting the NASDAQ 100 anytime soon, as it is clear that traders continue to look for value opportunities every time it pulls back. "

More news about NASDAQ 100 (NDX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com